Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,308 | 6,937 | 2,897 | 1,191 | 2,892 |
| TOTAL | $6,587 | $7,154 | $3,758 | $1,879 | $4,838 |
| Non-Current Assets | |||||
| PPE Net | 4 | 4 | 5 | 5 | 5 |
| Other Non-Current Assets | 994 | 1,024 | 1,047 | 1,345 | 99 |
| TOTAL | $998 | $1,028 | $1,052 | $1,350 | $104 |
| Total Assets | $7,585 | $8,182 | $4,810 | $3,229 | $4,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 727 | 786 | 553 | 881 | 712 |
| Accrued Expenses | 1,024 | 1,263 | 681 | 579 | 413 |
| TOTAL | $1,751 | $2,075 | $1,283 | $1,533 | $1,219 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1 | 2 |
| TOTAL | $N/A | $N/A | $N/A | $1 | $2 |
| Total Liabilities | $1,751 | $2,075 | $1,283 | $1,533 | $1,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,644 | 50,349 | 11,884 | 5,269 | 3,267 |
| Common Shares | 5 | 4 | 1 | 0 | 0 |
| Retained earnings | -97,424 | -93,988 | -90,054 | -87,219 | -84,491 |
| Other shareholders' equity | -300 | -300 | -300 | -300 | -300 |
| TOTAL | $5,834 | $6,107 | $3,527 | $1,696 | $3,721 |
| Total Liabilities And Equity | $7,585 | $8,182 | $4,810 | $3,229 | $4,942 |